Skip to main content
. Author manuscript; available in PMC: 2017 Aug 7.
Published in final edited form as: Antivir Ther. 2015 Aug 11;21(1):55–64. doi: 10.3851/IMP2982

Figure 2.

Figure 2

Virologic and immunologic response

Proportion of participants with HIV-1 RNA <50 and <200 copies/mL: Vertical bars are 95% Clopper-Pearson binomial confidence intervals. Intention-to-treat (ITT) analysis includes all participants regardless of treatment status, with missing HIV-1 RNA counted as failure. The as-treated denominator excludes participants who permanently discontinued ETR + TDF/FTC or had a missing HIV-1 RNA result.

Change in CD4+ count from baseline: Estimated median and 95% distribution-free confidence interval (vertical bars) are plotted at each study week. The intention-to-treat (ITT) analysis includes evaluable participants regardless of treatment status. The as-treated analysis excludes participants who permanently discontinued ETR + TDF/FTC before CD4+ count evaluation.